The filing of an international patent application typically indicates a significant advancement in a company's product offerings and intellectual property portfolio. For a biotech company like RenovoRx, such news is likely to be viewed positively by investors, as it suggests potential for market exclusivity and future revenue streams. This can lead to increased investor confidence and a rise in stock price in the short term.